David Francisco
First SEC filing: Feb. 17, 2022 · Latest: Feb. 17, 2022
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Feb. 18, 2026 | ORGO | A | 44,040 | · | · | 745,999 Direct | +6.27% | Acquired | (price as of 2026-10-05) |
| Feb. 18, 2026 | ORGO | F | 14,687 | $3.84 | $56,398 | 731,312 Direct | -1.97% | Disposed | -66.4% (price as of 2026-10-05) |
| Feb. 18, 2026 | ORGO | A | 195,312 | · | · | 701,959 Direct | +38.55% | Acquired | (price as of 2026-10-05) |
| Feb. 18, 2026 | ORGO | A | 43,602 | · | · | 745,561 Direct | +6.21% | Acquired | (price as of 2026-10-05) |
| Feb. 18, 2026 | ORGO | F | 14,541 | $3.84 | $55,837 | 731,020 Direct | -1.95% | Disposed | -66.4% (price as of 2026-10-05) |
| Feb. 18, 2026 | ORGO | A | 111,358 | · | · | 111,358 Direct | · | Acquired | (price as of 2026-10-05) |
| Feb. 15, 2026 | ORGO | F | 3,898 | $3.73 | $14,540 | 555,197 Direct | -0.70% | Disposed | -65.4% (price as of 2026-10-05) |
| Feb. 15, 2026 | ORGO | F | 21,412 | $3.73 | $79,867 | 533,785 Direct | -3.86% | Disposed | -65.4% (price as of 2026-10-05) |
| Feb. 15, 2026 | ORGO | F | 13,369 | $3.73 | $49,866 | 520,416 Direct | -2.50% | Disposed | -65.4% (price as of 2026-10-05) |
| Feb. 15, 2026 | ORGO | F | 13,769 | $3.73 | $51,358 | 506,647 Direct | -2.65% | Disposed | -65.4% (price as of 2026-10-05) |
| Feb. 19, 2025 | ORGO | A | 170,841 | · | · | 170,841 Direct | · | Acquired | (price as of 2026-10-05) |
| Feb. 19, 2025 | ORGO | A | 165,156 | · | · | 559,095 Direct | +41.92% | Acquired | (price as of 2026-10-05) |
| Feb. 16, 2025 | ORGO | F | 804 | $3.70 | $2,975 | 393,939 Direct | -0.20% | Disposed | -65.1% (price as of 2026-10-05) |
| Feb. 15, 2025 | ORGO | F | 2,960 | $3.70 | $10,952 | 394,743 Direct | -0.74% | Disposed | -65.1% (price as of 2026-10-05) |
| Feb. 15, 2025 | ORGO | F | 19,528 | $3.70 | $72,254 | 397,703 Direct | -4.68% | Disposed | -65.1% (price as of 2026-10-05) |
| Feb. 15, 2025 | ORGO | F | 11,765 | $3.70 | $43,530 | 417,231 Direct | -2.74% | Disposed | -65.1% (price as of 2026-10-05) |
| Feb. 21, 2024 | ORGO | A | 289,915 | · | · | 289,915 Direct | · | Acquired | (price as of 2026-10-05) |
| Feb. 21, 2024 | ORGO | A | 160,350 | · | · | 428,996 Direct | +59.69% | Acquired | (price as of 2026-10-05) |
| Feb. 16, 2024 | ORGO | F | 804 | $3.48 | $2,798 | 268,646 Direct | -0.30% | Disposed | -62.9% (price as of 2026-10-05) |
| Feb. 15, 2024 | ORGO | F | 3,513 | $3.68 | $12,928 | 269,450 Direct | -1.29% | Disposed | -64.9% (price as of 2026-10-05) |
| Feb. 15, 2024 | ORGO | F | 18,966 | $3.68 | $69,795 | 272,963 Direct | -6.50% | Disposed | -64.9% (price as of 2026-10-05) |
| Feb. 22, 2023 | ORGO | A | 287,892 | · | · | 287,892 Direct | · | Acquired | (price as of 2026-10-05) |
| Feb. 22, 2023 | ORGO | A | 242,508 | · | · | 291,929 Direct | +490.70% | Acquired | (price as of 2026-10-05) |
| Feb. 16, 2023 | ORGO | F | 953 | $2.75 | $2,621 | 49,421 Direct | -1.89% | Disposed | -53.1% (price as of 2026-10-05) |
| Feb. 15, 2023 | ORGO | F | 3,506 | $2.92 | $10,238 | 50,374 Direct | -6.51% | Disposed | -55.8% (price as of 2026-10-05) |
| Feb. 16, 2022 | ORGO | F | 953 | $7.78 | $7,414 | 53,880 Direct | -1.74% | Disposed | -83.4% (price as of 2026-10-05) |
| Feb. 15, 2022 | ORGO | F | 1,876 | $8.03 | $15,064 | 54,833 Direct | -3.31% | Disposed | -83.9% (price as of 2026-10-05) |
| Feb. 15, 2022 | ORGO | A | 95,692 | · | · | 95,692 Direct | · | Acquired | (price as of 2026-10-05) |
| Feb. 15, 2022 | ORGO | A | 40,348 | · | · | 56,709 Direct | +246.61% | Acquired | (price as of 2026-10-05) |
| Feb. 16, 2021 | ORGO | A | 10,965 | · | · | 16,361 Direct | +203.21% | Acquired | (price as of 2026-10-05) |
| Feb. 16, 2021 | ORGO | A | 83,955 | · | · | 83,955 Direct | · | Acquired | (price as of 2026-10-05) |
| Feb. 15, 2021 | ORGO | A | 5,396 | · | · | 5,396 Direct | · | Acquired | (price as of 2026-10-05) |
| Feb. 15, 2021 | ORGO | A | 43,239 | · | · | 43,239 Direct | · | Acquired | (price as of 2026-10-05) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Feb. 18, 2026 | ORGO | Stock Option (Right to Buy) | Class A Common Stock | $3.84 | Feb. 18, 2036 | 111,358 | Acquired |
| Feb. 19, 2025 | ORGO | Stock Option (Right to Buy) | Class A Common Stock | $3.53 | Feb. 19, 2035 | 170,841 | Acquired |
| Feb. 21, 2024 | ORGO | Stock Option (Right to Buy) | Class A Common Stock | $3.43 | Feb. 21, 2034 | 289,915 | Acquired |
| Feb. 22, 2023 | ORGO | Stock Option (Right to Buy) | Class A Common Stock | $2.51 | Feb. 22, 2033 | 287,892 | Acquired |
| Feb. 15, 2022 | ORGO | Stock Option (Right to Buy) | Class A Common Stock | $8.03 | Feb. 15, 2032 | 95,692 | Acquired |
| Feb. 16, 2021 | ORGO | Stock Option (Right to Buy) | Class A Common Stock | $13.68 | Feb. 16, 2031 | 83,955 | Acquired |
| Feb. 15, 2021 | ORGO | Stock Option (Right to Buy) | Class A Common Stock | $12.74 | Feb. 15, 2031 | 43,239 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2025 | $514,626 | · | · | · | $445,466 | · | $40,783 | $1,987,065 |
| 2024 | $469,268 | $32,463 | · | · | $389,553 | · | $35,221 | $2,025,754 |
| 2023 | $419,930 | $160,902 | · | · | · | · | $47,687 | $1,629,294 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.